While there was no notable decision this week, plenty of interesting issues percolated through the federal courts. Read on for the following: (1) the latest installment in the legal war between pharmacy benefit managers and the State of Arkansas over that state’s efforts to rein them in (Central States v. McClain); (2) the
It was another slow-ish week in ERISA-land, so we have no notable decision to highlight. However, read on to learn more about how (1) a wrongful death claim prompted by an astronomical increase in the price of an asthma inhaler is not preempted by ERISA (Schmidtknecht v. OptumRx Inc.), (2) pharmacy benefit managers have
It is a light and breezy week here in California and at Your ERISA Watch. So, we have no case of the week and just a few covered decisions. Of note is an interesting attorneys’ fee decision from the Sixth Circuit, and two decision on petitions for interlocutory review under 28 U.S.C. § 1292(b)